DBV Technologies S.A.

NasdaqCM:DBVT Stock Report

Market Cap: US$66.7m

DBV Technologies Future Growth

Future criteria checks 2/6

DBV Technologies is forecast to grow earnings and revenue by 6.5% and 59.6% per annum respectively while EPS is expected to decline by 11.3% per annum.

Key information

6.5%

Earnings growth rate

-11.3%

EPS growth rate

Biotechs earnings growth28.5%
Revenue growth rate59.6%
Future return on equityn/a
Analyst coverage

Low

Last updated25 Oct 2024

Recent future growth updates

No updates

Recent updates

FDA puts partial clinical hold on a DBT Technologies peanut allergy patch phase 3 trial

Sep 21

DBV Technologies GAAP EPS of -$0.35 misses by $0.03, revenue of $1.53M beats by $0.29M

Aug 01

DBV Technologies: Good Data, Plenty Of Cash And Regulatory Uncertainty

Jul 07

DBV Technologies reports change in U.S. reporting status, cuts headcount

Jan 07

DBV Technologies CSO Hugh Sampson to step down from role

Nov 24

DBV Technologies shares rockets 85% as EMA approves Viaskin Peanut application

Nov 02

Earnings and Revenue Growth Forecasts

NasdaqCM:DBVT - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20266-124-183-1191
12/31/20255-119-172-1141
12/31/20245-128-160-1102
9/30/202413-102-109-106N/A
6/30/202414-88-105-103N/A
3/31/202415-80-95-94N/A
12/31/202316-73-80-80N/A
9/30/20236-101-90-90N/A
6/30/20235-101-91-90N/A
3/31/20234-100-76-75N/A
12/31/20225-96-56-56N/A
9/30/20229-71-52-51N/A
6/30/20228-77-55-53N/A
3/31/20225-85-74-74N/A
12/31/20216-98-109-108N/A
9/30/20212-124-124-123N/A
6/30/20214-131-144-142N/A
3/31/20219-148-154-152N/A
12/31/202011-160-168-166N/A
9/30/202017-161-157-153N/A
6/30/202016-171-156-151N/A
3/31/202016-169-161-156N/A
12/31/201915-172-154-148N/A
9/30/201912-176-156-151N/A
6/30/201913-198-176-169N/A
3/31/201913-191-166-160N/A
12/31/201813-190-162-157N/A
9/30/201811-178-164-157N/A
6/30/201811-172N/A-145N/A
3/31/201811-182N/A-147N/A
12/31/201712-177N/A-137N/A
9/30/201711-169N/A-118N/A
6/30/201711-157N/A-97N/A
3/31/20179-135N/A-77N/A
12/31/20168-121N/A-63N/A
9/30/20168-109N/A-58N/A
6/30/20168-88N/A-49N/A
3/31/20168-72N/A-41N/A
12/31/20157-49N/A-29N/A
9/30/20156-40N/A-28N/A
6/30/20156-30N/A-25N/A
3/31/20155-27N/A-23N/A
12/31/20146-29N/A-25N/A
9/30/20146-30N/A-24N/A
6/30/20147-32N/A-25N/A
3/31/20146-28N/A-21N/A
12/31/20135-27N/A-18N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: DBVT is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: DBVT is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: DBVT is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: DBVT's revenue (59.6% per year) is forecast to grow faster than the US market (8.9% per year).

High Growth Revenue: DBVT's revenue (59.6% per year) is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if DBVT's Return on Equity is forecast to be high in 3 years time

Discover growth companies

7D

1Y

7D

1Y

7D

1Y